These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 31606391)

  • 1. Crosstalk of intracellular post-translational modifications in cancer.
    Wu Z; Huang R; Yuan L
    Arch Biochem Biophys; 2019 Nov; 676():108138. PubMed ID: 31606391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between phosphorylation and O-GlcNAcylation: friend or foe.
    van der Laarse SAM; Leney AC; Heck AJR
    FEBS J; 2018 Sep; 285(17):3152-3167. PubMed ID: 29717537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The next level of complexity: crosstalk of posttranslational modifications.
    Venne AS; Kollipara L; Zahedi RP
    Proteomics; 2014 Mar; 14(4-5):513-24. PubMed ID: 24339426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathological implication of protein post-translational modifications in cancer.
    Pan S; Chen R
    Mol Aspects Med; 2022 Aug; 86():101097. PubMed ID: 35400524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.
    Zhang Y; Zeng L
    Plant Commun; 2020 Jul; 1(4):100041. PubMed ID: 33367245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein Post-Translational Modification Crosstalk in Acute Myeloid Leukemia Calls for Action.
    Hernandez-Valladares M; Wangen R; Berven FS; Guldbrandsen A
    Curr Med Chem; 2019; 26(28):5317-5337. PubMed ID: 31241430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. dbPTM in 2019: exploring disease association and cross-talk of post-translational modifications.
    Huang KY; Lee TY; Kao HJ; Ma CT; Lee CC; Lin TH; Chang WC; Huang HD
    Nucleic Acids Res; 2019 Jan; 47(D1):D298-D308. PubMed ID: 30418626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of enriched PTM crosstalk motifs from large-scale experimental data sets.
    Peng M; Scholten A; Heck AJ; van Breukelen B
    J Proteome Res; 2014 Jan; 13(1):249-59. PubMed ID: 24087892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoding Post-Translational Modification Crosstalk With Proteomics.
    Leutert M; Entwisle SW; Villén J
    Mol Cell Proteomics; 2021; 20():100129. PubMed ID: 34339852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Strategies for Probing the Biological Functions of Protein Post-translational Modifications in Mammalian Cells with Genetic Code Expansion.
    Ding W; Zhao H; Chen Y; Lin S
    Acc Chem Res; 2023 Oct; 56(20):2827-2837. PubMed ID: 37793174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development.
    Leeming DJ; Bay-Jensen AC; Vassiliadis E; Larsen MR; Henriksen K; Karsdal MA
    Biomarkers; 2011 May; 16(3):193-205. PubMed ID: 21506694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-translational modifications of proteins in cardiovascular diseases examined by proteomic approaches.
    Stastna M
    FEBS J; 2024 Mar; ():. PubMed ID: 38440918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein Language: Post-Translational Modifications Talking to Each Other.
    Vu LD; Gevaert K; De Smet I
    Trends Plant Sci; 2018 Dec; 23(12):1068-1080. PubMed ID: 30279071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Post-translational Proteome with Intrabodies.
    Cattaneo A; Chirichella M
    Trends Biotechnol; 2019 Jun; 37(6):578-591. PubMed ID: 30577991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilizing a Comprehensive Immunoprecipitation Enrichment System to Identify an Endogenous Post-translational Modification Profile for Target Proteins.
    Horita H; Law A; Middleton K
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29364248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Role of Unconventional Post-Translational Modifications in Cancer Diagnostics and Therapy.
    Sharma S; Sarkar O; Ghosh R
    Curr Protein Pept Sci; 2024; 25(10):780-796. PubMed ID: 38910429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of post-translational modifications by chemical and computational proteomics.
    Yang F; Wang C
    Chem Commun (Camb); 2020 Nov; 56(88):13506-13519. PubMed ID: 33084662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-Translational Modifications in sperm Proteome: The Chemistry of Proteome diversifications in the Pathophysiology of male factor infertility.
    Samanta L; Swain N; Ayaz A; Venugopal V; Agarwal A
    Biochim Biophys Acta; 2016 Jul; 1860(7):1450-65. PubMed ID: 27062907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modifications in the cellular proteome and their clinical application.
    Elguero B; Gonilski Pacin D; Cárdenas Figueroa C; Fuertes M; Arzt E
    Medicina (B Aires); 2019; 79(Spec 6/1):570-575. PubMed ID: 31864228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structural and functional signatures of proteins that undergo multiple events of post-translational modification.
    Pejaver V; Hsu WL; Xin F; Dunker AK; Uversky VN; Radivojac P
    Protein Sci; 2014 Aug; 23(8):1077-93. PubMed ID: 24888500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.